Sii

Dengue vaccine: Phase-3 trial likely from Aug-Sept

Maharashtra: Current Covid variants are mild, SII has produced 5-6 million Covovax doses, says Adar Poonawalla

Ghana first country to approve SII-Oxford made high-efficacy malaria vax

Serum Institute seeks drug regulator's approval for market authorisation of its Covid vaccine as booster dose

SII stopped Covishield production in Dec 2021, says Poonawalla

Serum Institute case: Stolen money transferred to banks in five states

Poonawalla appeals to utilise learnings from COVID to strengthen health systems globally

SII seeks permission for Phase-3 trial of Covovax as booster dose in children aged 2 to 18 years

SII lowers each dose of Covovax jab from Rs 900 to Rs 225 excluding taxes

SII to give free Covishield vials to pvt vaccination centres to compensate for price difference

SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults

DGCI gives nod to SII's proposal to manufacture vaccine against omicron for test, analysis

SII applies to Indian authorities for full market authorisation of Covishield

Dr S.S. Jadhav, who helped develop SII's Covishield, dies in Pune

SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns